Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 3

1.

The selectivity of protein kinase inhibitors: a further update.

Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H, Klevernic I, Arthur JS, Alessi DR, Cohen P.

Biochem J. 2007 Dec 15;408(3):297-315.

2.

New inhibitors of the PI3K-Akt-mTOR pathway: insights into mTOR signaling from a new generation of Tor Kinase Domain Inhibitors (TORKinibs).

Feldman ME, Shokat KM.

Curr Top Microbiol Immunol. 2010;347:241-62. doi: 10.1007/82_2010_64. Review.

PMID:
20549474
3.

Identification of selective inhibitors of cdc2-like kinases 1 and 4 (Clk1, Clk4).

Coombs TC, Tanega C, Shen M, Neuenswander B, Porubsky P, Wang JL, Misteli T, Auld DS, Schoenen F, Thomas CJ, Aubé J.

Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-.
2012 Apr 16 [updated 2013 May 8].

Supplemental Content

Support Center